Overview of short-term and long-term safety of brexpiprazole in patients with major depressive disorder and inadequate response to antidepressant treatment

JC Nelson, P Zhang, A Skuban… - Current Psychiatry …, 2016 - ingentaconnect.com
Background: Many patients with major depressive disorder (MDD) do not respond
adequately to first-line antidepressant treatment (ADT). Adjunctive treatment with second …
被引用次数：22 相关文章

Overview of short-term and long-term safety of brexpiprazole in patients with major depressive disorder and inadequate response to antidepressant treatment.

JC Nelson, P Zhang, A Skuban, M Hobart… - Current Psychiatry …, 2016 - psycnet.apa.org
Background: Many patients with major depressive disorder (MDD) do not respond
adequately to first-line antidepressant treatment (ADT). Adjunctive treatment with second …
[PDF] academia.edu

[PDF][PDF] Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant …

JC Nelsona, P Zhangb, A Skubanb… - Current Psychiatry …, 2016 - academia.edu
Background: Many patients with major depressive disorder (MDD) do not respond
adequately to first-line antidepressant treatment (ADT). Adjunctive treatment with second …